A detailed history of California State Teachers Retirement System transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 30,942 shares of ORIC stock, worth $255,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,942
Previous 35,104 11.86%
Holding current value
$255,271
Previous $248,000 27.82%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $11.9 $31,298 - $49,527
-4,162 Reduced 11.86%
30,942 $317,000
Q2 2024

Aug 14, 2024

BUY
$6.63 - $12.93 $206,723 - $403,157
31,180 Added 794.6%
35,104 $248,000
Q1 2024

May 15, 2024

SELL
$8.04 - $16.03 $20,108 - $40,091
-2,501 Reduced 38.93%
3,924 $53,000
Q4 2023

Feb 13, 2024

SELL
$5.41 - $9.43 $11,831 - $20,623
-2,187 Reduced 25.39%
6,425 $59,000
Q3 2023

Nov 14, 2023

SELL
$6.05 - $9.28 $26,450 - $40,572
-4,372 Reduced 33.67%
8,612 $52,000
Q2 2023

Aug 21, 2023

BUY
$4.95 - $8.4 $64,270 - $109,065
12,984 New
12,984 $100,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $7.07 $97,113 - $254,293
-35,968 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.54 - $16.1 $11,168 - $39,606
-2,460 Reduced 6.4%
35,968 $192,000
Q4 2021

Feb 15, 2022

BUY
$12.01 - $20.3 $23,839 - $40,295
1,985 Added 5.45%
38,428 $565,000
Q3 2021

Nov 15, 2021

SELL
$15.9 - $25.22 $67,447 - $106,983
-4,242 Reduced 10.43%
36,443 $762,000
Q2 2021

Aug 16, 2021

BUY
$17.37 - $25.34 $114,572 - $167,142
6,596 Added 19.35%
40,685 $720,000
Q1 2021

May 18, 2021

BUY
$23.67 - $36.85 $12,545 - $19,530
530 Added 1.58%
34,089 $835,000
Q4 2020

Feb 16, 2021

BUY
$20.32 - $39.8 $415,137 - $813,114
20,430 Added 155.61%
33,559 $1.14 Million
Q2 2020

Aug 17, 2020

BUY
$25.68 - $38.12 $337,152 - $500,477
13,129 New
13,129 $443,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $327M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.